AstraZeneca (AZN) Stock Forecast & Price Target

AZN$178.57-3.69 -2.03%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$276.95BEnterprise value$311.89BRevenue (TTM)$62.17BMarket positionTop 5%

Score

55
Neutral
Value
45
Quality
63
Growth
56

AstraZeneca PLC price target

AZN
Low$206.00
Average$211.00
High$216.00
Upside vs current price+18.2%

The average target of $211.00 is +18.2% versus the current AZN price of $178.57.

AstraZeneca PLC analyst ratings

RatingAnalysts
Strong buy2
Buy7
Hold2
Sell1
Strong sell0
ConsensusBuy

12 analysts cover AZN.

AstraZeneca PLC EPS and revenue estimates

Published annual figures for AZN on this page are 2026 EPS $10.26, 2027 EPS $11.35. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$10.26$62.71B
2027$11.35$66.79B

Is AstraZeneca PLC a buy or sell?

Of the 12 analysts covering AstraZeneca PLC, 9 rate it a buy (2 strong buy and 7 buy), 2 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).

The AZN consensus label is Buy, beside 9 buy-side ratings and 1 sell-side ratings.

The average target of $211.00 implies +18.2% versus the current price of $178.57.

The AZN rating block is 12 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the AstraZeneca PLC forecast

the AstraZeneca PLC has a tight target cluster: $206.00 to $216.00, average $211.00.

The gap from the $178.57 price to the AZN average is +18.2%.

The AZN rating mix is lopsided rather than split: 9 of 12 analysts are on the buy side, 2 are at hold, and 1 is on the sell side, and the published consensus is Buy.

the AstraZeneca PLC has a rising EPS path, $10.26 for 2026 and $11.35 for 2027.

With 12 analysts on AZN, the average is a small sample.

AstraZeneca PLC forecast questions

What is the AZN price target?

The published range for AZN is $206.00 to $216.00, with an average of $211.00. That average is +18.2% versus the current price of $178.57.

Is AstraZeneca PLC a buy or sell?

Of the 12 analysts covering AstraZeneca PLC, 9 rate it a buy, 2 rate it a hold, and 1 rates it a sell. The consensus is Buy, leaving AZN at 9 buy ratings, 2 holds, and 1 sells.

What is the EPS estimate for AstraZeneca PLC?

Analyst EPS estimates for AstraZeneca PLC: 2026 $10.26, 2027 $11.35.

What is the revenue estimate for AstraZeneca PLC?

Analyst revenue estimates for AstraZeneca PLC: 2026 $62.71B, 2027 $66.79B.

How many analysts cover AZN?

12 analysts cover AZN. Their consensus on AZN is Buy, across those 12.

AZN price $178.57 -3.69 -2.03%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener